Equities

Henan Taloph Pharmaceutical Stock Co Ltd

600222:SHH

Henan Taloph Pharmaceutical Stock Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)4.32
  • Today's Change-0.12 / -2.70%
  • Shares traded9.57m
  • 1 Year change-18.49%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments328327616
Total Receivables, Net1,1121,093808
Total Inventory455450382
Prepaid expenses7510188
Other current assets, total226050
Total current assets1,9932,0311,944
Property, plant & equipment, net577597587
Goodwill, net286286286
Intangibles, net777673
Long term investments523494826
Note receivable - long term------
Other long term assets------
Total assets3,5773,6073,784
LIABILITIES
Accounts payable430439256
Accrued expenses314427
Notes payable/short-term debt6356621,143
Current portion long-term debt/capital leases10418142
Other current liabilities, total45056383
Total current liabilities1,6501,7261,650
Total long term debt27323092
Total debt1,0129091,377
Deferred income tax2533132
Minority interest4544117
Other liabilities, total4.873.33132
Total liabilities1,9982,0362,123
SHAREHOLDERS EQUITY
Common stock574574574
Additional paid-in capital675675588
Retained earnings (accumulated deficit)281237232
Treasury stock - common(80)(38)(49)
Unrealized gain (loss)128122315
Other equity, total------
Total equity1,5781,5701,661
Total liabilities & shareholders' equity3,5773,6073,784
Total common shares outstanding559567563
Treasury shares - common primary issue157.2011
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.